FDA approves first contact lens indicated to slow the progression of nearsightedness in children (Myopia Control)
- For Immediate Release:
The U.S. Food and Drug Administration today approved the first contact lens indicated to slow the progression of myopia (nearsightedness) in children between the ages of 8 and 12 years old at the initiation of treatment. The MiSight contact lens is a single use, disposable, soft contact lens that is discarded at the end of each day, and is not intended to be worn overnight.
“Today’s approval is the first FDA-approved product to slow the progression of myopia in children, which ultimately could mean a reduced risk of developing other eye problems,” said Malvina Eydelman, M.D., director of the Office of Ophthalmic, Anesthesia, Respiratory, ENT and Dental Devices in the FDA’s Center for Devices and Radiological Health.
Myopia is the most frequent cause of correctable visual impairment worldwide. Myopia occurs when the eye grows too long from front to back (axial length). Instead of focusing images on the retina, images are focused at a point in front of the retina. As a result, people with myopia have good near vision, but poor distance vision that can be corrected with glasses or contact lenses. Click Here to continue the story.
Myopia Control in Baltimore can not only provide improvement to your children’s schooling, sports activities, and overall success, but more importantly, prevents the risk of ocular disease. Discover more about myopia control at our practice in Timonium.
If you or a loved has been diagnosed with Myopia then contact the doctors at the Myopia Control Center of Maryland to learn if Myopia Control is right for you!
